[1] Soria JC, Ohe Y, Vansteenkiste J, et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer [J]. New Engl J Med, 2018,378(2):113-115. [2] 汪宁,王婷,崔巍,等.二甲双胍对晚期非小细胞肺癌合并糖尿病 患者生存期影响的研究[J].山西医药杂志,2019,48(7):784-786. [3] 高旭峰,张莉,杨之斌.二甲双胍对结肠癌合并2型糖尿病患者预 后的影响[J].实用肿瘤杂志,2019,31(2):118-121. [4] Marrone KA, Zhou X, Forde PM,et al. A randomized phaseⅡstudy of metformin plus paclitaxel/carboplatin/beva-cizumab in patients with chemotherapy- nave advanced or metastatic nonsquamous non- small cell lung cancer [J]. Oncologist,2018,23(7):465-466. [5] 王高祥,徐美青,解明然.二甲双胍抗肺癌机制研究进展[J].中国 肺癌杂志,2020,23(4):282-285. [6] 王雪,纪国欣,纪超,等.二甲双胍对合并2型糖尿病的Ⅰ型子宫内 膜癌患者预后的影响[J].国际肿瘤学杂志,2020,47(7):404-408. [7] 王蕾,吴益康,马骏,等.2型糖尿病患者的恶性肿瘤发病风险:基于 浙江省嘉兴市糖尿病管理数据的回顾性队列研究[J].肿瘤,2019, 39(7):548-557. [8] 刘萤照,冯雁,王琪.二甲双胍调控miRNAs抑制恶性肿瘤机制研 究进展[J].基础医学与临床,2018,38(8):1158-1162. [9] 杨怀勇,黎麟达.双歧杆菌三联活菌胶囊联合二甲双胍治疗对结 直肠癌合并2型糖尿病患者血糖控制和临床疗效[J].昆明医科大 学学报,2020,41(4):111-116. [10] Xu C, Liu WB, Zhang DD,et al. Interactions between dietary carbohydrate and metformin: Implications on energy sensing, insulin signaling pathway, glycolipid metabolism and glucose tolerance in blunt snout bream Megalobrama amblycephala [J]. Aquaculture, 2018,28(30):183-195. [11] Juan E Blüme, Eugenio Arteaga, Sócrates Aedo, et al. Metformin use is associated with a lower risk of osteoporo-sis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC Ⅸstudy [J]. Gynecol Endocrinol, 2020,36(5):421-425. [12] 熊德明,胡斌,徐耀凤,等.二甲双胍与同步放化疗联合应用于局 部晚期非小细胞肺癌治疗中的临床效果[J].实用癌症杂志,2018, 33(5):797-800. [13] 陈晴晴,束军,谢庆书,等.二甲双胍丁酸盐对人肺腺癌A549细胞 增殖、凋亡与迁移能力的影响[J].安徽医科大学学报,2018,20(2): 171-175. [14] 吴丹丹,王雪融.二甲双胍抗头颈部肿瘤的研究进展[J].药物评价 研究,2018,41(12):250-254. [15] 李宇,徐瑾,贺会清,等.二甲双胍对甲状腺乳头状癌TPC-1细胞 凋亡的影响及其机制研究[J].临床内科杂志,2019,36(12):838-841. [16] Xin WX, Fang L, Fang QL,et al. Effect of hypoglyce-mic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta- analysis [J]. Medicine, 2018,97(9):e35-e37.